Trent U. Steidinger, Ph.D. - Related publications

Affiliations: 
2012 Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Parkinson's disease
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Inose Y, Izumi Y, Takada-Takatori Y, Akaike A, Koyama Y, Kaneko S, Kume T. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1. Neuroscience Letters. 736: 135268. PMID 32712353 DOI: 10.1016/j.neulet.2020.135268   
2020 Pajares M, I Rojo A, Manda G, Boscá L, Cuadrado A. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications. Cells. 9. PMID 32674367 DOI: 10.3390/cells9071687   
2020 Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain, Behavior, and Immunity. PMID 32739365 DOI: 10.1016/j.bbi.2020.07.036   
2020 Lei K, Shen Y, He Y, Zhang L, Zhang J, Tong W, Xu Y, Jin L. Baicalin Represses C/EBP via Its Antioxidative Effect in Parkinson's Disease. Oxidative Medicine and Cellular Longevity. 2020: 8951907. PMID 32566108 DOI: 10.1155/2020/8951907   
2020 Huang Y, Sun L, Zhu S, Xu L, Liu S, Yuan C, Guo Y, Wang X. Neuroprotection Against Parkinson's Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A. Frontiers in Neuroscience. 14: 723. PMID 32742256 DOI: 10.3389/fnins.2020.00723   
2020 Leem YH, Park JS, Park JE, Kim DY, Kang JL, Kim HS. Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 130: 110576. PMID 32768884 DOI: 10.1016/j.biopha.2020.110576   
2020 Tsai RT, Tsai CW, Liu SP, Gao JX, Kuo YH, Chao PM, Hung HS, Shyu WC, Lin SZ, Fu RH. Maackiain Ameliorates 6-Hydroxydopamine and Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in and the SH-SY5Y Cell Line. International Journal of Molecular Sciences. 21. PMID 32585871 DOI: 10.3390/ijms21124455   
2020 Chang YM, Manoj Kumar M, Lu CY, Te Tsai C, Tsai CC, Liao PH, Lin SL, Chang CC, Mahalakshmi B, Kuo WW, Huang CY. Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review. Life Sciences. 118019. PMID 32629002 DOI: 10.1016/j.lfs.2020.118019   
2020 Ferreira C, Almeida C, Tenreiro S, Quintas A. Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease. Life (Basel, Switzerland). 10. PMID 32545328 DOI: 10.3390/life10060086   
2020 Yang L, Mao K, Yu H, Chen J. Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 32529463 DOI: 10.1007/s11481-020-09926-7   
2020 Von Seggern M, Szarowicz C, Swanson M, Cavotta S, Pike ST, Lamberts JT. Purine molecules in Parkinson's disease: analytical techniques and clinical implications. Neurochemistry International. 104793. PMID 32650026 DOI: 10.1016/j.neuint.2020.104793   
2020 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nature Reviews. Gastroenterology & Hepatology. PMID 32737460 DOI: 10.1038/s41575-020-0339-z   
2020 Chen H, Cao J, Zha L, Wang P, Liu Z, Guo B, Zhang G, Sun Y, Zhang Z, Wang Y. Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1α and BDNF/CREB pathways. Aging. 12. PMID 32710729 DOI: 10.18632/aging.103551   
2020 Rui W, Li S, Xiao H, Xiao M, Shi J. Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/caspase-1/GSDMD Pathway in MPTP Induced Mice Model of Parkinson's Disease. The International Journal of Neuropsychopharmacology. PMID 32761175 DOI: 10.1093/ijnp/pyaa060   
2020 Lv Q, Wang Z, Zhong Z, Huang W. Role of Long Noncoding RNAs in Parkinson's Disease: Putative Biomarkers and Therapeutic Targets. Parkinson's Disease. 2020: 5374307. PMID 32617144 DOI: 10.1155/2020/5374307   
2020 Getachew B, Csoka AB, Bhatti A, Copeland RL, Tizabi Y. Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease. Neurotoxicity Research. PMID 32572814 DOI: 10.1007/s12640-020-00238-5   
2020 Wändell P, Fredrikson S, Carlsson AC, Li X, Sundquist J, Sundquist K. Parkinson's Disease Among Immigrant Groups and Swedish-Born Individuals: A Cohort Study of All Adults 50 Years of Age and Older in Sweden. Journal of Parkinson's Disease. PMID 32568106 DOI: 10.3233/JPD-201962   
2020 Wändell P, Fredrikson S, Carlsson AC, Li X, Sundquist J, Sundquist K. Parkinson's Disease Among Immigrant Groups and Swedish-Born Individuals: A Cohort Study of All Adults 50 Years of Age and Older in Sweden. Journal of Parkinson's Disease. PMID 32568106 DOI: 10.3233/JPD-201962   
2020 Chang KH, Chen CM. The Role of Oxidative Stress in Parkinson's Disease. Antioxidants (Basel, Switzerland). 9. PMID 32650609 DOI: 10.3390/antiox9070597   
2020 Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, Betsou F, Krüger R, Thiele I, . Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. Bmc Biology. 18: 62. PMID 32517799 DOI: 10.1186/s12915-020-00775-7   
2020 Yang L, Zhang X, Li S, Wang H, Zhang X, Liu L, Xie A. Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway. Life Sciences. 118159. PMID 32763288 DOI: 10.1016/j.lfs.2020.118159   
2020 Belloli S, Morari M, Murtaj V, Valtorta S, Moresco RM, Gilardi MC. Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation. Frontiers in Aging Neuroscience. 12: 152. PMID 32581765 DOI: 10.3389/fnagi.2020.00152   
2020 Boertien JM, van der Zee S, Chrysou A, Gerritsen MJJ, Jansonius NM, Spikman JM, van Laar T, . Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology. Bmc Neurology. 20: 245. PMID 32534583 DOI: 10.1186/s12883-020-01811-3   
2020 Kam TI, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in parkinson's disease. Neurobiology of Disease. 105028. PMID 32736085 DOI: 10.1016/j.nbd.2020.105028   
2020 Yu J, Min D, Bai Y, Qu L, Zou T, Wang S. Electroacupuncture alleviates Parkinson disease and regulates the expression of brain-gut peptides. Experimental Animals. PMID 32669479 DOI: 10.1538/expanim.19-0153   
2020 Yu J, Min D, Bai Y, Qu L, Zou T, Wang S. Electroacupuncture alleviates Parkinson disease and regulates the expression of brain-gut peptides. Experimental Animals. PMID 32669479 DOI: 10.1538/expanim.19-0153   
2020 Li W, Goshima Y, Ohshima T. Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson's Disease. Neurochemical Research. PMID 32648145 DOI: 10.1007/s11064-020-03086-z   
2020 Hernández-Vara J, Sáez-Francàs N, Lorenzo-Bosquet C, Corominas-Roso M, Cuberas-Borròs G, Lucas-Del Pozo S, Carter S, Armengol-Bellapart M, Castell-Conesa J. BDNF levels and nigrostriatal degeneration in "drug naïve" Parkinson's disease patients. An "in vivo" study using I-123-FP-CIT SPECT. Parkinsonism & Related Disorders. 78: 31-35. PMID 32682292 DOI: 10.1016/j.parkreldis.2020.06.037   
2020 Cubo E, Martínez-Martín P, González-Bernal J, Casas E, Arnaiz S, Miranda J, Gámez P, Santos-García D, . Effects of Motor Symptom Laterality on Clinical Manifestations and Quality of Life in Parkinson's Disease. Journal of Parkinson's Disease. PMID 32741839 DOI: 10.3233/JPD-202067   
2020 Naz F, Rahul, Fatima M, Naseem S, Khan W, Mondal AC, Siddique YH. Ropinirole silver nanocomposite attenuates neurodegeneration in the transgenic Drosophila melanogaster model of Parkinson's disease. Neuropharmacology. 108216. PMID 32707222 DOI: 10.1016/j.neuropharm.2020.108216   
2020 Zhao H, Huang S, Palanisamy S, Wang C, Rainer G, Zhang X. Alpha-synuclein Dopaminylation Presented in Plasma of Both Healthy Subjects and Parkinson's Disease Patients. Proteomics. Clinical Applications. e1900117. PMID 32538547 DOI: 10.1002/prca.201900117   
2020 Østergaard FG, Himmelberg MM, Laursen B, Siebner HR, Wade AR, Christensen KV. Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing. Scientific Reports. 10: 11869. PMID 32681050 DOI: 10.1038/s41598-020-68808-3   
2020 Sportelli C, Urso D, Jenner P, Chaudhuri KR. Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-Viewpoint. Frontiers in Neurology. 11: 556. PMID 32595595 DOI: 10.3389/fneur.2020.00556   
2020 Hoban DB, Shrigley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Nelander Wahlestedt J, Luk KC, Björklund A, Parmar M. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD. Proceedings of the National Academy of Sciences of the United States of America. PMID 32541058 DOI: 10.1073/pnas.2001305117   
2020 Huang J, Hong W, Yang Z, Ding J, Ren Y. Efficacy of pramipexole combined with levodopa for Parkinson's disease treatment and their effects on QOL and serum TNF- levels. The Journal of International Medical Research. 48: 300060520922449. PMID 32735501 DOI: 10.1177/0300060520922449   
2020 Awogbindin IO, Ishola IO, St-Pierre MK, Carrier M, Savage JC, Di Paolo T, Tremblay MÈ. Remodeling microglia to a protective phenotype in Parkinson's disease? Neuroscience Letters. 135164. PMID 32561452 DOI: 10.1016/j.neulet.2020.135164   
2020 Duan WJ, Liang L, Pan MH, Lu DH, Wang TM, Li SB, Zhong HB, Yang XJ, Cheng Y, Liu B, Li WX, Kurihara H, Bi W, Li YF, He RR. Theacrine, a purine alkaloid from kucha, protects against Parkinson's disease through SIRT3 activation. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 77: 153281. PMID 32707370 DOI: 10.1016/j.phymed.2020.153281   
2020 Gonçalves AR, Mendes A, Vila-Chã N, Damásio J, Fernandes J, Cavaco SM. Past appendectomy may be related to early cognitive dysfunction in Parkinson's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 32529319 DOI: 10.1007/s10072-020-04507-1   
2020 Raina A, Leite K, Guerin S, Mahajani SU, Chakrabarti KS, Voll D, Becker S, Griesinger C, Bähr M, Kügler S. Dopamine promotes the neurodegenerative potential of β-synuclein. Journal of Neurochemistry. PMID 32730640 DOI: 10.1111/jnc.15134   
2020 Yong VW, Tan YJ, Ng YD, Choo XY, Sugumaran K, Chinna K, Md Shah MN, Raja Aman RRA, Moy FM, Mohd Ramli N, Grossmann M, Lim SY, Tan AH. Progressive and accelerated weight and body fat loss in Parkinson's disease: A three-year prospective longitudinal study. Parkinsonism & Related Disorders. 77: 28-35. PMID 32615497 DOI: 10.1016/j.parkreldis.2020.06.015   
2020 Hossein-Tehrani MR, Ghaedian T, Hooshmandi E, Kalhor L, Foroughi AA, Ostovan VR. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32557946 DOI: 10.1111/jon.12740   
2020 Wang M, Ling KH, Tan JJ, Lu CB. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside. Cells. 9. PMID 32570916 DOI: 10.3390/cells9061489   
2020 Angelopoulou E, Paudel YN, Shaikh MF, Piperi C. Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications. Pharmacological Research. 158: 104930. PMID 32445958 DOI: 10.1016/j.phrs.2020.104930   
2020 Wang Y, Wang Q, Yu R, Zhang Q, Zhang Z, Li H, Ren C, Yang R, Niu H. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression. Aging. 12. PMID 32706757 DOI: 10.18632/aging.103440   
2020 Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Parkinson's Disease. 6: 11. PMID 32566740 DOI: 10.1038/s41531-020-0112-6   
2020 Kang X, Ploner A, Ludvigsson JF, Williams DM, Larsson H, Pedersen NL, Wirdefeldt K. Clostridium difficile infection and risk of Parkinson's disease: A Swedish population-based cohort study. European Journal of Neurology. PMID 32538502 DOI: 10.1111/ene.14400   
2020 Campbell MC, Myers PS, Weigand AJ, Foster ER, Cairns NJ, Jackson JJ, Lessov-Schlaggar CN, Perlmutter JS. Parkinson disease clinical subtypes: key features & clinical milestones. Annals of Clinical and Translational Neurology. PMID 32602253 DOI: 10.1002/acn3.51102   
2020 El-Ghaiesh SH, Bahr HI, Ibrahiem AT, Ghorab D, Alomar SY, Farag NE, Zaitone SA. Metformin Protects From Rotenone-Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis. Frontiers in Molecular Neuroscience. 13: 84. PMID 32625061 DOI: 10.3389/fnmol.2020.00084   
2020 Hanan M, Simchovitz A, Yayon N, Vaknine S, Cohen-Fultheim R, Karmon M, Madrer N, Rohrlich TM, Maman M, Bennett ER, Greenberg DS, Meshorer E, Levanon EY, Soreq H, Kadener S. A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress. Embo Molecular Medicine. e11942. PMID 32715657 DOI: 10.15252/emmm.201911942   
2020 Joers V, Masilamoni G, Kempf D, Weiss AR, Rotterman TM, Murray B, Yalcin-Cakmakli G, Voll RJ, Goodman MM, Howell L, Bachevalier J, Green S, Naqib A, Shaikh M, Engen P, et al. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series. Neurobiology of Disease. 105027. PMID 32712266 DOI: 10.1016/j.nbd.2020.105027